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To date, the signal transducing adaptor molecule 2 (STAM2) was shown to harbour two ubiquitin
binding domains (UBDs) known as the VHS and UIM domains, while the SH3 domain of STAM2
was reported to interact with deubiquitinating enzymes (DUBs) like UBPY and AMSH. In the present
study, NMR evidences the interaction of the STAM2 SH3 domain with ubiquitin, demonstrating that
SH3 constitutes the third UBD of STAM2. Furthermore, we show that a UBPY-derived peptide can
outcompete ubiquitin for SH3 binding and vice versa. These results suggest that the SH3 domain
of STAM2 plays versatile roles in the context of ubiquitin mediated receptor sorting.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The turnover of many membrane proteins is subtly regulated
through the endocytic pathway, where receptor cargoes are direc-
ted to the lysosome for degradation or recycled. Modiﬁcation of
receptors by mono- or Lys63-linked polyubiquitination constitutes
a trafﬁcking signal that is deciphered and executed by the ESCRT
machinery [1–3]. The ESCRT-0 complex, which is the most
upstream component of the ESCRT system, is constituted of the
STAM (signal transducing adaptor molecule) and Hrs (hepatocyte
growth factor-regulated substrate) proteins. Each of them harbours
multiple modular motifs known as ubiquitin binding domains
(UBDs) [4], the function of which is to recognize the ubiquitin
tag and usher cargoes along the endocytic pathway. To date, two
UBDs known as VHS (Vps27/Hrs/STAM) [5] and UIM (ubiquitinchemical Societies. Published by E
es required for transport; Ub,
3, Src homology 3 domain;
ody; Hrs, hepatocyte growth
ing adaptor molecule; VHS,
BPY/USP8, ubiquitin-speciﬁc
AMSH, associated molecule
alker).interacting motif) [6] were identiﬁed in the STAM protein while
Hrs possesses a VHS and a DUIM (double ubiquitin interacting mo-
tif) domain [7]. Removal of the ubiquitin (Ub) tag is achieved by
deubiquitinating enzymes (DUBs) that are implicated in diverse
cellular pathways [8]. Among the different DUBs, AMSH and UBPY
are involved in lysosomal degradation and have been shown to
interact directly with the ESCRT system and more precisely with
the SH3 domain of STAM [9–11]. The interaction of DUBs with
STAM is essential to drive activated receptors into the recycling
pathway [9]. In addition, UBPY protects STAM and Hrs from prote-
asomal degradation [12], which is required for the proper function-
ing and integrity of the ESCRT machinery [13]. In the present
article, NMR titration and spin relaxation experiments reveal, that
both the UIM and SH3 domains of the STAM2 UIM-SH3 construct,
can bind to a ubiquitin (Ub) molecule. This important ﬁnding dem-
onstrates that the SH3 domain constitutes the third UBD of STAM2.
By using a UIMI181E-SH3 mutant, we also demonstrate that the SH3
domain can still bind Ub when Ub binding is abolished on the UIM
domain. Furthermore, NMR competition assays show that a UBPY
peptide can outcompete Ub for binding to the SH3 domain. Our re-
sults clearly demonstrate that the DUB binding function of the
STAM2 SH3 domain is not exclusive and that SH3 could be
involved in the concentration of ubiquitinated cargoes at the
ESCRT-0 level as well.lsevier B.V. All rights reserved.
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2.1. Protein expression and puriﬁcation
STAM2162-265 (UIM-SH3) was puriﬁed as previously described
for STAM21-149 (VHS) [14]. The TEV cleavage reaction left a N-ter-
minal extensions GAMGM for STAM2162-265. The Ubwt was pro-
duced as described in refs [15–17]. The UIMI181E-SH3 variant was
engineered using site-directed mutagenesis. The UBPY peptide
has been purchased from ‘‘Genosphere’’.2.2. NMR experiments
The ensemble of NMR experiments was acquired at 288 K
where the NMR samples were exchanged into a buffer containing
20 mM sodium phosphate at pH 6.8, 10% D2O, 0.02% (w/v) NaN3.
Assignment and spin-relaxation experiments have been carried
out on a Varian Inova Unity 600 equipped with a triple-resonance
probe.2.3. Protein resonance assignment
The backbone resonance assignment for UIM-SH3 was obtained
using a combination of the following experiments: [15N, 1H]-HSQC,
HNCA, HNCACB and 3D NOESY-[15N, 1H]-HSQC. Data were pro-
cessed with NMRpipe [18] and analyzed with NMRview [19]. The
UIM-SH3 sequence was renumbered according to the STAM2-
VHS structure (PDB code 1X5B) by adding 7 to the STAM2 sequence
(Uniprot accession number O75886).2.4. Relaxation measurements and analysis
Relaxation measurements including 15N longitudinal (R1),
transverse (R2) relaxation and the 15N-1H cross-relaxation rates
via steady-state 15N{1H}NOE were performed as previously de-
scribed [20,21]. NMR spectra were recorded with spectral widths
of 2000 Hz in the 15N dimension and 9600 Hz in the 1H dimension.
For the R1 measurements, we used twelve relaxation delays: 4, 20,
40, 80 (twice), 240, 480, 800 (twice), 1200, 1400, 1600, 1800 and
2000 ms with a recycling delay of 4 s. The R2 CPMG measurements
were performed with transverse relaxation period of 4, 12, 24, 32
(twice), 40, 48, 56, 80, 120 (twice), 160 and 200 ms and a relaxa-
tion delay of 4 s. For 15N{1H} NOE experiments, 2D spectra were re-
corded with and without presaturation of amide protons. The
relaxation delay was set to six seconds in order to allow the bulk
water magnetization to return as close as possible to its equilib-
rium value. All NMR data were processed with NMRpipe [18] and
analyzed with SPARKY [22], and the relaxation rates were ex-
tracted using RelaxFit [21].2.5. NMR titration studies
Interaction surfaces on 15N-monoUb and 15N-UIM-SH3 were
characterized by means of chemical shift perturbations (CSPs)
where a series of 1H, 15N-HSQC experiments were recorded upon
addition of the (unlabeled) binding partner. To avoid possible
aggregation of the proteins, we started from a 15N-labeled protein
at a concentration of 200 lM and added an increasing volume of a
concentrated stock of unlabeled ligand protein until reaching satu-
ration. To derive the corresponding binding constant, spectral per-
turbations were quantiﬁed as the combined amide CSPs:
Dd = [(DdH)2 + (DdN/5)2]1/2. The corresponding equations used to
derive Kds from the UIM-SH3 or Ub side can be found in Supple-
mentary data.2.6. Homology modeling of UIM and UIM-SH3
The 3D structure of the UIM part in the UIM-SH3 construct was
obtained by homology modeling following a methodology similar
to the modeling of the VHS-UIM construct [23]. The amino acid se-
quences of STAM2-UIM and Vps27-UIM1 share 55% identity and
70% similarity. We used the UIM1 domain [24] of Vps27 (PDB code
1Q0V) to model the structure of the UIM part of the UIM-SH3 con-
struct, while the STAM2 SH3 domain (PDB code 1X2Q) was used to
model the SH3 part of the UIM-SH3 construct. Models were gener-
ated by using the Modeller program [25]. After alignment of the
query and template sequences with Align2D, they were used as in-
put in Modeller. A total of ten structures were generated for the
UIM-SH3 construct.3. Results
3.1. Structural and dynamical properties of the UIM-SH3 construct
The structure of the UIM-SH3 construct has been obtained by
homology modelling (see Section 2). The UIM domain folds into
an a-helix, as supported by chemical shift index (CSI) [26] and Ta-
los+ [27]. This result is in agreement with our previous structural
prediction of the UIM part of the VHS-UIM construct [23]. The
complete UIM-SH3 backbone assignment is available from BioMa-
gResBank under the accession number 18403. To characterize the
dynamical properties of the UIM-SH3 construct, we used spin
relaxation measurement as it reports on the overall rotational dif-
fusion and structure of molecules. Measurements of the 15N longi-
tudinal (R1) as well as the transverse relaxation rate (R2) indicate
that the SH3 and the UIM domains tumble essentially indepen-
dently (see Fig. S1). The average R2 values measured for the SH3
and the UIM domains in UIM-SH3 are 10.4 ± 0.3 and 6.5 ± 0.1 s1,
respectively. Moreover, the steady-state 15N{1H}NOE shows that
the 16 amino acid linker separating the SH3 and UIM domain is
highly ﬂexible. Model-free analysis of relaxation data indicates
that the UIM domain is highly dynamic in the ps-ns time scale.
The average squared order parameter (S2) for the UIM part is
0.67 ± 0.06, which reﬂects a greater amplitude of the backbone mo-
tion compared to the SH3 part (S2 = 0.88 ± 0.05).
3.2. The SH3 domain of STAM2 interacts with ubiquitin
In the 1H, 15N-HSQC spectrum of UIM-SH3, the UIM part over-
laps with its spectrum as isolated unit (see Figs. S2 and S3). This
fact provides clear evidence that the SH3 and UIM domains do
not interact with each other in the UIM-SH3 construct. To map
the interaction of the UIM-SH3 construct with Ub we monitored
chemical shift perturbations (CSPs) in 1H, 15N-HSQC spectra of
15N-labeled UIM-SH3 or Ub upon addition of the corresponding
unlabeled binding partner. As illustrated on Fig. 1A, several resi-
dues of the UIM part in the UIM-SH3 construct present signiﬁcant
CSPs while some showed a strong decrease of their signal intensi-
ties, indicative of intermediate exchange. Speciﬁcally, hydrophobic
residues Ile177, Ala178, Ile181 and Leu185, as well as negatively
charged residues Asp174 and Glu182 exhibit strong signal attenu-
ations. Furthermore, based on CSPs, our results suggest a highly
speciﬁc interaction surface between the SH3 domain and Ub,
mainly mediated by hydrophobic contacts (see Figs. 1A,C and S4).
The strongest perturbations include the hydrophobic residues
Phe220, Ala222, Val223, Phe230, Trp247 and Leu267 as well as
an adjacent region formed by negatively charged residues
Asp219, Glu221, Glu227 and Glu234. From the 15N-Ub side, the
UIM-SH3 construct mainly targets hydrophobic residues including
Ile13, Ile44, Leu50 and Val70 while Ala46 and Gly47 experience
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Fig. 1. NMRmapping of the interface between UIM-SH3 and Ub. Shown are chemical shift perturbations (CSPs) observed in UIM-SH3 at the endpoint of titration with Ub (A),
and in Ub (B) upon saturation with UIM-SH3. Gray bars indicate residues experiencing intermediate exchange on the NMR time scale, resulting in strong attenuations of their
signals in the 1H, 15N-HSQC spectra. (C) Mapping of the residues affected by UIM-SH3/Ub binding on the 3D structure of UIM-SH3 (the UIM-SH3 structure was obtained by
homology modeling, see Section 2) and Ub (D). In the UIM part of UIM-SH3, residues in intermediate exchange are colored red while residues with signiﬁcant CSPs (Dd > 0.2)
are colored light blue. In the SH3 part of UIM-SH3, residues with signiﬁcant CSPs (Dd > 0.1) are colored red. In Ub, residues with signiﬁcant CSPs (Dd > 0.2) and/or
intermediate exchange are colored red.
Table 1
Summary of the dissociation constants derived from NMR titration curves for the
UIM-SH3/Ub and UIM-SH3/UBPY binding equilibria.a
Sample Domain analyzed Kd (lM)
UIM-SH3/Ub SH3 500 (55)b
UIM 338 (42)b
Ub 308 (32)c
UIM-SH3/UBPY SH3 5(4)b
UIMI181E-SH3/Ub SH3 411 (48)b
UIM 14000 (1330)b
a Kds are averaged over several residues that showed strong CSPs upon binding.
Standard deviations are shown in parentheses.
b Data were ﬁt using a two-sites binding equation n1 (see Supplementary data).
c Data were ﬁt using a two-sites binding equation n2 (see Supplementary data).
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also include charged residues Arg42, Lys48 and Arg72.
3.3. Stoichiometry and dissociation constant of the UIM-SH3/Ub
complex
15N transverse relaxation (R2) was used as a ‘‘molecular ruler’’
[23] to determine the mass of the molecular complexes under
investigation (Fig. S5) and was carried out on both sides of the
complex in saturating conditions. On a 15N-UIM-SH3 sample satu-
rated by Ub, the average R2 for residues in secondary structure is
12.4 ± 0.8 and 13.6 ± 1.0 s1 for the UIM and SH3 part, respectively.
These values correspond to a molecular mass of 14.0–16.4 kDa and
15.5–18.6 kDa, respectively and are in good agreement with the
values expected when a Ub binds to each domain of the UIM-
SH3 construct (12.0 and 15.0 kDa, respectively). As a sake of com-
parison, we measured the 15N transverse relaxation R2 on a UI-
MI181E-SH3 mutant saturated by Ub. While the Ub binding to
UIM is abolished, the SH3 part still remains capable of Ub binding
(see Fig. S8). We derived a R2 value of 14.3 ± 1.7 s1 (see Fig. S1 and
S5) while the corresponding R2 value for the isolated UIM domain
upon binding to Ub is 11.5 ± 0.5 s1 [23]. Thus, the average R2 val-
ues determined for the individual UIM and UIM part in UIM-SH3upon binding to Ub are similar. Likewise, the average R2 values
for the SH3 part in UIM-SH3 or UIMI181E-SH3 measured under sat-
urating conditions with Ub are comparable. These results clearly
indicate that the UIM and SH3 part of the UIM-SH3 construct still
reorient independently when binding to Ub.
From titration curves (Fig. S6), we derived a dissociation
constant (Kd) of 338 ± 42 and 500 ± 55 lM for the UIM and SH3
domain upon binding to Ub (see Table 1). Taking into account
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about 50 lM, it is noteworthy that the SH3 domain is the weakest
Ub binder among the other UBDs of STAM2 [14,23]. As previously
determined, the dissociation constant related to the binding of the
individual UIM with Ub is 290 ± 25 lM [23]. Additionally, the Kd
determined for the SH3 part in UIMI181E-SH3 upon Ub binding is
411 ± 48 lM. Thus, the dissociation constants seen for the binding
of the individual UIM or the UIM part in UIM-SH3 to Ub are similar.
In the same order of idea, Kds measured for the SH3 part in UIM-
SH3 or UIMI181E-SH3 when binding to Ub are also of the same order
of magnitude. This ensemble of results strongly supports the fact
that the binding of UIM-SH3 to Ub does not involve any synergetic
effect between the UIM and SH3 parts.
3.4. UBPY competes with Ub for SH3 association
As stated in previous studies, the deubiquitinating enzyme
UBPY encodes an extended region that contains three RXXK motifs,
which constitute binding partners for the SH3 domain of STAM2
[9,28]. Furthermore, the PX(V/I)(D/N)RXXKP motif, found in UBPY,
has been reported to interact with the STAM2 SH3 domain [29,30].
Kaneko et al. have previously reported the crystal structure of a
UBPY-derived peptide (TPMVNRENKPP) in interaction with STAM2
SH3 [10]. Comparing the crystal structure of the SH3/UBPY peptide
complex with the CSPs of the SH3/Ub complex indicates an overlap
of the two binding sites. Therefore, this naturally raises the ques-
tion ‘‘Is the SH3 domain of STAM2 capable of handling two binding
partners at the same time or do they compete for SH3 binding?’’7.9
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Fig. 2. Competition assays show that the UBPY peptide can outcompete Ub for binding
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Ub complex upon UBPY peptide titration. Gray bars indicate residues experiencing inter
signals in the 1H, 15N-HSQC spectra. (D) Mapping of the residues affected by the UIM-SH3
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containing the TPMVNRENKPP sequence. The UBPY peptide bind-
ing to SH3 was monitored on 15N-UIM-SH3 1H, 15N-HSQC experi-
ments by adding an increasing amount of unlabelled UBPY
peptide until a [UBPY]:[UIM-SH3] ratio of 3:1. As can be seen on
Fig. 2A, only the SH3 domain is affected by the addition of the UBPY
peptide. Perturbations are mainly located on the SH3 RT loop and
involve residues Asp219, Glu221, Asp241, Ser242, Trp246 and
Leu257 while Asp225, Asn226 and Leu228 exhibit strong signal
attenuation early in the titration (see Fig. 2D), indicative of inter-
mediate exchange. From titration curves (Fig. S7A), we derived a
dissociation constant of 5 ± 4 lM for the SH3/UBPY peptide com-
plex, which is of the same order of magnitude compared to the va-
lue determined by ﬂuorescence spectroscopy [10]. In order to
directly compare the afﬁnities of UBPY and Ub for SH3, we carried
out competition assays. Starting from a preformed UIM-SH3/UBPY
sample, we added Ub at a [UBPY]:[Ub] ratio of 2:1. As can be seen
on Fig. 2B, the addition of Ub does not induce signiﬁcant perturba-
tions on the SH3 domain, while residues located on the UIM do-
main are strongly affected. Conversely, starting from a
[UBPY]:[UIM-SH3] ratio of 1:2 and adding an increasing amount
of Ub until a [UBPY]:[Ub] ratio of 1:13, caused 15N-UIM-SH3 sig-
nals to shift to the position they occupied for the UIM-SH3/Ub
complex (see Fig. S7B). This observation is further conﬁrmed by
the reverse competition assay. The addition of the UBPY peptide
to a preformed 15N-UIM-SH3/Ub complex at a [UBPY]:[Ub] ratio
of 2:1 caused Ub-perturbed 15N-UIM-SH3 signals to shift back to
the position they occupied for the 15N-UIM-SH3/UBPY complex6
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the presence of the UIM part, we performed competition experi-
ments on a preformed 15N-UIMI181E-SH3/Ub complex (Fig. S8A,B)
by adding the UBPY peptide until reaching saturation. As can be
seen on Fig. S9, signiﬁcant perturbations occur on the SH3 domain
only and are similar to the CSPs seen for the competition experi-
ments carried out on a preformed UIM-SH3/Ub complex upon
binding to UBPY. These results strongly support the fact that the
competitive binding of UBPY and Ub for SH3 is independent from
the UIM part.
4. Discussion
SH3 domains are known to mediate protein-protein interac-
tions, while their main target are proline-rich ligands with a PXXP
consensus sequence [31]. Besides this motif they were found to
bind to a PX(V/I)(D/N)RXXKP motif and ubiquitin hydrophopic
patch. The main function of the STAM2 SH3 domain is the recruit-
ment of deubiquitinating enzymes while no binding to Ub has been
reported so far [28]. Our results demonstrate that the SH3 domain
of STAM2 constitutes the third UBD of STAM2, also capable of
interacting with a speciﬁc region on UBPY. The SH3/Ub and the
SH3/UBPY interaction surfaces overlap and mainly encompass
three regions known as the RT loop, n-Src loop and a 310-helix
(see Fig. 3). Our results clearly show that a UBPY peptide outcom-
petes Ub for SH3 binding at a [UBPY]:[Ub] ratio of 2:1. Conversely,
at a [UBPY]:[Ub] ratio of 1:13, Ub can supersede UBPY. It should be
borne in mind, however, that we cannot exclude different results in
terms of afﬁnity when the complete UBPY protein is used.
Additionally, we have shown that the binding capabilities of
SH3 still remain when Ub binding is abolished on UIM (see Supple-
mentary data and Figs. S8 and S9). Although, the SH3 domain of
several proteins is known to bind proline-enriched motifs of the
type PXXP [31,32] or RXXK [33], its Ub binding capability is likely
to be linked to subtle changes in its sequence. Indeed, the three
SH3 domains of CIN85 and the SH3-3 domain of Sla1 demonstrate
Ub binding capabilities whereas the SH3-1 domain of Sla1 and the
Grb2 SH3 domain do not exhibit discernible Ub binding activity
[34–36]. One of the reported hypotheses is related to the presence
of a phenylalanine in the SH3 sequence (Phe262 for the STAM2
SH3) and mutation of this amino acid abolished Ub binding [36]
whereas binding to PXXP motifs still remained [35]. The fact that
UBPY outcompetes Ub for SH3 binding naturally raises the ques-
tion: ‘‘What is the role of the STAM2 SH3 domain in the endocytic
pathway?’’ STAM2 is a member of the ESCRT system, which de-
codes the ubiquitin signal at different control points and mediates
further sorting events along the endocytic pathway [37–39].Understanding the role played by the SH3 domain is rather compli-
cated by the fact that its interacting partners Ub and UBPY are both
part of the endosomal sorting machinery. For instance, the balance
between UBPY and E3 might also determine protein fate by virtue
of direct deubiquitination of activated receptors [9,12,40,41]. UBPY
is also involved in the protection of STAM2 from proteasomal deg-
radation [12,42,43]. Besides its protective role toward STAM or Hrs,
through its interaction with STAM, UBPY is involved in directing
ubiquitinated cargoes either to the lysosome or recycling them
back to the plasma membrane through its interaction with STAM2
[9].
One of the possible hypotheses that might explain the compet-
itive binding between Ub and UBPY to SH3, is based on the concen-
tration of ubiquitinated cargo and is supported by our
experimental observations. In case of low concentrations of ubiqui-
tinated cargoes, UBPY would bind to SH3, resulting in deubiquiti-
nation and recycling of the cargo protein. Inversely, at high cargo
concentration, Ub would supersede UBPY and, therefore, prevent
cargo proteins from recycling. This situation could take place after
extensive stimulation of receptors like EGFR leading to degradation
and de-sensitization of the cell, while slight stimulation of the
receptor would result in recycling and re-sensitization. Of course,
this hypothesis needs further inquiries and biological assays. It is
also worth mentioning that the presence of three UBDs in STAM2
raises further questions. We previously demonstrated that the
interaction of the VHS-UIM domain with K63-linked diubiquitin
is cooperative [23]. Therefore, we can legitimately wonder whether
the interaction of the UIM-SH3 construct with Lys63-linked
diubiquitin is cooperative as well, or, in the same order of idea,
whether Lys63-linked triubiquitin chains have a better efﬁciency
in cargo sorting, compared to Lys63- or Lys48-linked diubiquitin
chains? Our results illustrate the multifaceted landscape of UBDs,
especially when they are not solely binding Ub, but rather bind
other proteins involved in the same regulatory machinery.
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